Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04503421 · ClinicalTrials.gov registry record · NA
Use of Blood Flow Restriction (BFR) Therapy in Post-operative Rehabilitation Following Distal Biceps Tendon Repair
A NA study, sponsored by Henry Ford Health System.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
NCT04503421 is a NA study that has completed, run by Henry Ford Health System. The registered enrollment target is 64 participants.
The verdict
NCT04503421, a NA study, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
Study Summary
The goal of this investigation is to determine if using BFR during postoperative therapy would lead to increased and expedited strength gains. Additionally, the investigators would like to determine if BFR is beneficial in preventing muscle atrophy and fatty infiltration in the setting of bicep tendon tears, due to the altered tension-length relationship following surgery. The study will also look at patient reported outcomes metrics and pain scores to determine if BFR has a significant impact on the patient experience surrounding distal biceps tear and surgical repair
Interventions
- OTHER Blood Flow Restriction Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2020-08-15 |
| Est. Completion | 2021-09-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04503421
The ClinicalTrials.gov registry entry for NCT04503421 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood Flow Restriction Therapy is the first listed.
NCT04503421 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04503421 about?
NCT04503421 is a clinical study titled "Use of Blood Flow Restriction (BFR) Therapy in Post-operative Rehabilitation Following Distal Biceps Tendon Repair". The goal of this investigation is to determine if using BFR during postoperative therapy would lead to increased and expedited strength gains. Additionally, the investigators would like to determine if BFR is beneficial in preventing muscle atrophy and fatty infiltration in the setting of bicep tend...
What is the current status of trial NCT04503421?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2020-08-15. Estimated completion is 2021-09-15.
What interventions are being tested in trial NCT04503421?
The interventions under investigation include: Blood Flow Restriction Therapy (OTHER).
Who is sponsoring clinical trial NCT04503421?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.